Leap Therapeutics shares owned by Key Client Fiduciary Advisors
Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Key Client Fiduciary Advisors
from 13F filings
Historical chart of Key Client Fiduciary Advisors investment in Leap Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Leap Therapeutics held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Leap Therapeutics by Key Client Fiduciary Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $63k | 138k | 0.45 |
| 2025-06-30 | $102k | 344k | 0.30 |
| 2025-03-31 | $119k | 389k | 0.31 |
| 2024-12-31 | $1.0M | 361k | 2.88 |
| 2024-09-30 | $827k | 322k | 2.57 |
| 2024-06-30 | $558k | 285k | 1.96 |
| 2024-03-31 | $620k | 233k | 2.66 |
| 2023-12-31 | $890k | 215k | 4.15 |
| 2023-09-30 | $314k | 227k | 1.38 |
| 2023-06-30 | $496k | 159k | 3.13 |
More positions owned by Key Client Fiduciary Advisors
View all positions for Key Client Fiduciary Advisors